Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI
NCT01140321
Anemia, Anemia, Hemolytic
Brindisi, Italy
View Trial DetailsNCT Number: NCT00006138
OBJECTIVES:
I. Determine the frequency and severity of osteopenia and osteoporosis in patients with thalassemia major who undergo dual energy x-ray absorptiometry, and correlate these findings with other relevant endocrinologic measurements.
Looking for future studies?
Notify Me6 year and older
All sexes
Observational
PROTOCOL OUTLINE:
Patients undergo dual energy x-ray absorptiometry for bone density measurements, height (sitting and standing) and weight measurements, comprehensive endocrinologic examination, and assessment of the severity of iron overload at baseline, and then at years 1 and 2.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
National Center for Research Resources (NCRR)
Nih
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01140321
Anemia, Anemia, Hemolytic
Brindisi, Italy
View Trial DetailsNCT05541432
Behavior, Bone Diseases
Waterloo, Ontario, Canada
View Trial DetailsNCT03483584
Avitaminosis, Bone Diseases
Shatin, Hong Kong
View Trial DetailsNCT04079868
Bone Diseases, Bone Diseases, Metabolic
Durham, North Carolina, United States
View Trial Details